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A new protein was cloned and identified as the sixth
member of the human origin recognition complex
(ORC). The newly identified 30-kDa protein hsORC6 is
28% identical and 49% similar to ORC6p from Drosophila
melanogaster, which is consistent with the identities
and similarities found among the other ORC members
reported in the two species. The human ORC6 gene is
located on chromosome 16q12. ORC6 protein level did
not change through the cell cycle. Like ORC1, ORC6 did
not co-immunoprecipitate with other ORC subunits but
was localized in the nucleus along with the other ORC
subunits. Several cellular proteins co-immunoprecipi-
tated with ORC6, including a 65-kDa protein that was
hyperphosphorylated in G1 and dephosphorylated in
mitosis. Therefore, unlike the tight stoichiometric asso-
ciation of six yeast ORC subunits in one holo-complex,
only a small fraction of human ORC1 and ORC6 is likely
to be associated with a subcomplex of ORC2, 3, 4, and 5,
suggesting differences in the architecture and regula-
tion of human ORC.
Initiation of eukaryotic DNA replication takes place at mul-
tiple sites in the genome. In yeast Saccharomyces cerevisiae, a
six protein origin recognition complex (ORC)1 binds to ARS
consensus sequences in a sequence-specific manner (1, 2). All
six ORC subunits are essential for cell viability and DNA
replication (1–6). In Xenopus laevis and in Drosophila melano-
gaster, a six-protein complex similar to that found in S. cerevi-
siae has been reported (7, 8). Xenopus egg extracts depleted of
the ORC subunits can regain replication activity when xlORC
preparations are added back into the replication reaction (7).
Recombinant dmORC preparation can rescue the DNA repli-
cation activity of ORC depleted Xenopus and Drosophila egg
extracts (9). Genetic experiments in Drosophila have shown
that ORC2 and ORC3 are essential for DNA replication (10,
11). These results lead to the conclusion that ORC is essential
for DNA replication in higher eukaryotes. However, in meta-
zoans, the DNA sequences essential for replication initiation
still remain elusive.
The eukaryotic DNA replication model derived from the ev-
idence in yeast S. cerevisiae suggests that ORC remains bound
to origins of DNA replication throughout the cell cycle (12, 13).
In G1, CDC6 is loaded on chromatin in ORC-dependent manner
that in effect facilitates the assembly of MCM2–7 (13–15). In
vitro studies in Xenopus egg extracts also show that ORC
recruits essential replication factors to the DNA (16, 17). For-
mation of this prereplicative complex is the key to initiate
chromosomal DNA replication at the onset of S phase. Re-
cently, in Xenopus and in Schizosaccharomyces pombe, a pro-
tein, called CDT1, essential for DNA replication has been re-
ported to be associated with the prereplicative chromatin in an
ORC-dependent manner (18, 19). Like CDC6, CDT1 is also
required for MCM loading on chromatin. As replication pro-
ceeds the MCM and CDC6 proteins are removed from the
chromatin to prevent rereplication.
Although conservation of structure and function is expected
between yeast ORC and metazoan ORC, several differences
have emerged. Five members of human ORC have been re-
ported so far (11, 20–25). HsORC1, 2, 4, and 5 have consider-
able homology with their yeast and Drosophila counterparts.
HsORC3, in contrast, shows poor homology with yeast scORC3
but significant homology with dmORC3 (11). HsORC2, 3, 4,
and 5 physically interact with each other, but biochemical
interaction of hsORC1 with other hsORC subunits has not been
established so far under endogenous levels of expression. In S.
pombe, the N-terminal half of the spORC4 contains an AT-hook
region that is unique to fission yeast (26, 27). These discrepan-
cies clearly suggest that the behavior of individual ORC sub-
units may not be conserved perfectly among different eukary-
otic species, although collectively they may play a similar role
in DNA replication.
Here we report the cloning and expression of the sixth mem-
ber of human ORC, the hsORC6 molecule homologous to
dmORC6. Identifying hsORC6 will lead us to our ultimate goal
of reconstituting the human ORC in vitro. Like hsORC3, the
homology between scORC6 and hsORC6 is poor. Like ORC1,
ORC6 did not interact with other ORC subunits under our
experimental conditions. Therefore, the architecture of human
ORC may be different from its yeast and Drosophila counter-
parts. We also found that several unidentified cellular proteins
interact with hsORC6, which may be useful to get an insight on
the function of human ORC.
EXPERIMENTAL PROCEDURES
Cloning of ORC6—The ORC6 clone in expressed sequence tag
177464 contains the entire open reading frame except the first ATG.
The CCATGG sequence was reconstituted by polymerase chain reaction
primer mutagenesis, and the cDNA from the ATG to the 39 end were
cloned between EcoRI (59) and XhoI sites of pBluescript SK(2), to give
pSK-ORC6. The entire sequence was confirmed by automated sequenc-
ing of appropriate deletion constructs and use of a few synthetic
primers.
Raising Antibody and Immunoprecipitation—ORC6 cDNA from
pSK-ORC6 was cloned in pET14b plasmid between NdeI and BamHI to
express ORC6 protein fused to a His6 epitope tag. The protein was
produced in bacteria followed by purification on a nickel resin column.
The purified protein was used to raise antibodies in rabbits (Co-calico
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Biologicals). Antibodies against human hsORC1, hsORC2, hsORC3,
hsORC4, and hsORC5 have been described elsewhere (11, 22, 23, 28).
Cyclin A antibodies were purchased from Santa Cruz Biotechnologies.
Immunoprecipitation and immunoblotting of cell lysates were carried
out using standard protocols.
Cell Synchronization and [35S]Methionine and 32PO4 Labeling of
Cellular Proteins—Exponentially growing HeLa cells were arrested for
24 h with 40 ng/ml of nocodazole at M phase, with 10 mM hydroxyurea
at early S phase, or with 5 mg/ml of aphidicolin at the G1/S transition
point. For synchronization at G1, asynchronous cells were arrested for
36–48 h with mevastatin (10 mM). For metabolic labeling with [35S]me-
thionine, cells were incubated for 2 h in medium lacking methionine
and then incubated overnight in medium supplemented to a final con-
centration of 3 mM cold methionine plus 200 mCi (34 pm) of [35S]methi-
onine (PerkinElmer Life Sciences; 1175 Ci/mmol) in the presence of
respective drugs. For [32P]orthophosphate labeling of cellular proteins,
synchronized cells were first incubated in phosphate-free medium for
2 h and then in medium containing 350 mCi (80 pM) of [32P]orthophos-
phate (PerkinElmer Life Sciences; 8500 Ci/mmol) for another 3 h in the
presence of respective drugs before harvesting them.
Immunofluorescence—U2OS cells were fixed in 3% formaldehyde
containing 2% sucrose at room temperature for 10 min, washed twice
with phosphate-buffered saline (PBS) and permeabilized in Triton so-
lution (3% bovine serum albumin, 0.5% Triton X-100 in PBS) for 5 min.
Cells were then incubated at room temperature for 45 min with anti-
ORC6 antibody (1:500 dilution) followed by three washes in 13 PBS.
Finally cells were incubated with the secondary antibody (fluorescein
isothiocyanate-conjugated swine anti-rabbit immunoglobulin G) at
room temperature for 30 min followed by three washes with PBS. Cells
were stained briefly with 49,6-diamidino-2-phenylindole and photo-
graphed under a fluorescent microscope.
Gel Filtration—5 3 106 293T cells were lysed in 0.15 M Nonidet P-40
lysis buffer containing 50 mM Tris, pH 8.0, 0.1% Nonidet P-40, 150 mM
NaCl, 50 mM NaF, 1 mM Na3VO4, 5 mM EDTA, 2 mM dithiothreitol, 1
mM phenylmethylsulfonyl fluoride, 2 mg/ml pepstatin A, 2 mg/ml leu-
peptin, and 5 mg/ml aprotitin for 1 h at 4 °C. The lysate was then
incubated at 37 °C for 15 min in the presence of 1000 units/ml DNaseI
supplemented with 5 mM MgCl2. The lysate was centrifuged (15000 3 g
for 20 min at 4 °C) and filtered through a 0.22-mm filter. The filtrate
was passed through fast protein liquid chromatography Superose 12
(Amersham Pharmacia Biotech) column using lysis buffer at a flow rate
of 0.2 ml/min. Alternate fractions were separated on 12% SDS-poly-
acrylamide gels and immunoblotted with anti-ORC2 and ORC6
antibodies.
RESULTS
Cloning and Sequence Analysis of Human ORC6—While
searching the data base to get possible candidates for putative
hsORC6 subunit, we found expressed sequence tags with con-
siderable homology with Drosophila ORC6 subunit. The entire
ORC6 sequence was reconstituted from two cDNA clones; IM-
AGE:199024 (H83116) and expressed sequence tag 177464
(AA306512). The entire sequence has been deposited in the
data base by Dr. M. O’Donnell and co-workers (GenBankTM
accession number NM014321), and the only difference is that
the 59 end of ORC6 begins from 19 of the deposited sequence
(Table I). Ours is the first published report on this new ORC6
subunit. The cDNA encoded an open reading frame correspond-
ing to 252 amino acids with a predicted molecular mass of ;28
kDa. The predicted molecular mass is very close to that of
dmORC6 (31 kDa) and a 29 kDa unidentified protein in xlORC
(7, 8). An alignment of the ORC6 subunit in human, Drosoph-
ila, S. pombe, and S. cerevisiae is shown in Fig. 1A. The
polypeptide is significantly homologous to the ORC6 subunit of
Drosophila (28% identical and 49% similar) over the entire
coding region (Fig. 1, A and B). This degree of homology be-
tween hsORC6 and dmORC6 is in good agreement with the
homology of other five human and Drosophila ORC subunits
(Fig. 1B). The homology of the Drosophila and human ORC6
subunit with S. cerevisiae ORC6 is low (5% identical and 19%
similar; 6% identical and 15% similar, respectively) (Fig. 1, A
and C). The S. pombe ORC6 is also significantly different from
S. cerevisiae ORC6 (27). These results suggest that ORC6 has
evolved faster than the other ORC subunits in eukaryotes.
HsORC6 Is Located at Chromosome 16q12—BLAST search
using the cDNA sequence of ORC6 showed a significant homol-
ogy with a human BAC clone (accession number AC007225)
located at chromosome 16q12. Comparing those two sequences
we found the intron-exon boundaries of ORC6 (Table I). The
mRNA is transcribed from 7 exons spanning over a 9-kilobase
region in the genome. The nucleotide sequence analysis of
genomic sequence upstream from the start site of the cDNA did
not show any obvious E2F transcription factor binding site,
suggesting that ORC6 mRNA level may not be cell-cycle regu-
lated. This is consistent with the steady expression of other
ORC subunits through the cell cycle but different from the
promoters of ORC1 and CDC6, which have E2F binding sites
and whose mRNA is cell cycle regulated (28, 29).
ORC6 Protein Level Is Unchanged throughout the Cell Cy-
cle—To examine ORC6 protein in the cell extract, a polyclonal
antiserum was raised against bacterially produced His6-tagged
ORC6p. It recognizes the bacterially expressed His6-tagged
antigen. The antiserum also recognizes a single 30-kDa protein
in 293T cell extract (Fig. 2A) that is very close to the predicted
mass of 28 kDa.
To examine whether ORC6 protein levels change through the
phases of the cell cycle, HeLa cells were blocked at M phase
using nocodazole and released over a time period of 24 h.
Western blot analysis of protein samples at various stages of
cell cycle clearly shows that the total level of ORC6p is not
significantly changed throughout the cell cycle (Fig. 2B). Nor-
mal progression of the cell cycle was indicated by the periodic
expression of cyclin A, which is normally induced at the G1/S
transition and degraded in M phase. The expression level of
ORC2p is also not changed significantly over the same course of
time (Fig. 2B). ORC1p, ORC3p, ORC4p, and ORC5p expression
levels also remain unchanged through the cell cycle (11, 22, 23,
30).
ORC6 Protein Does Not Interact with Other hsORC Sub-
units—We wanted to examine whether the newly identified
putative human ORC6 physically interacts with other hsORC
subunits. Immunoprecipitation of 293T cell extract using anti-
ORC2 antibody specifically co-precipitated hsORC3, 4, and 5
subunits (Fig. 3). ORC6 was not immunoprecipitated by anti-
ORC2 antibody under these experimental conditions. Simi-
larly, ORC1 was also not present in the anti-ORC2 immuno-
precipitates. Conversely, immunoprecipitation using anti-
TABLE I
Sequences of exon-intron boundaries of ORC6
Sequences of the introns are given in lowercase letters, and those of exons are in uppercase letters. The numbers in the parentheses are
nucleotide coordinates of the exon sequences assuming that the start of the cDNA (GenBank™ accession number NM 014321) is nucleotide 9. First
eight nucleotides of the cDNA are adapter sequences. A of ATG is nucleotide 49.
Exon I (9–113) ttcgttgaccCGCGGCGTTC. . . . ACATGCTGAGgtgagttcgg . . .
Exon II (114–243) ttttaaccagGAAAGCAGAG. . . . CTTGGACAGGgtaagtaggt . . .
Exon III (244–407) cctttcacagGCTTATTTAA. . . . TACTAAAAAGgtatggggca . . .
Exon IV (408–497) tctcctttagCTATGAGTCC. . . . CAGCATGCAAgtaggtattt . . .
Exon V (498–610) ttgttttgtaGATTCTAAAG. . . . CAGGTCGACAgtaagtattc . . .
Exon VI (611–679) cttcttaaagGAGAACCTGG. . . . CCAGCAAAGGgtaagtttta . . .
Exon VII (680–1621) tttctgtcagAAATGGAGAA. . . . ATGCATTCAAgttgtacttg.
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ORC6 antibody did not co-precipitate any of the other ORC
subunits from 293T cell extract. Identical results were obtained
from a HeLa cell line.
Gel Filtration of ORC6 Subunit from 293T Cell Extract—
ORC6 did not co-immunoprecipitate with any other ORC sub-
unit under our extraction conditions. We were interested to see
FIG. 1. Comparison of protein sequences of human ORC6 (hsORC6), D. melanogaster ORC6 (dmORC6), S. pombe ORC6 (spORC6),
and S. cerevisiae ORC6 (scORC6). A, alignment of protein sequences of hsORC6, dmORC6, spORC6, and scORC6. The alignment and shading
was performed using GeneDoc program. Identical residues are marked by dark shading, and similar residues are marked by light shading. The
numbers on the right indicate the amino acid residues of ORC6 in each species. B, bar diagram, light bars indicate percent identity of hsORC
subunits with those of dmORC counterparts, whereas dark bars show the percentage of similarity among them. C, bar diagram shows the identities
and similarities between human and S. cerevisiae ORC subunits.
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whether the majority of ORC6p exists as monomers or multim-
ers in the cell. ORC6 could also be present in a larger complex
with other ORC subunits without any stable direct interaction
among them. To investigate these issues, a 293T cell extract
(150 mM NaCl, 0.1% Nonidet P-40) was passed through Super-
ose 12 gel filtration column. Alternate fractions were immuno-
blotted with anti-ORC6 antibodies (Fig. 4). ORC6 peaked in
fraction 21, consistent with a complex of 200 kDa, suggesting
that either this protein is a multimer or associated with other
cellular proteins. Although ORC2 level peaked at an earlier
fraction (fraction 19) than ORC6, a reasonable quantity of
ORC6 overlapped with ORC2 peak fraction. Therefore, there
remains the theoretical possibility that small fractions of ORC2
and ORC6 proteins are part of a larger complex that is dis-
rupted by immunoprecipitation with either anti-ORC2 or anti-
ORC6 antibodies.
ORC6p Interacts with Unidentified Cellular Proteins—Be-
cause ORC6 did not co-immunoprecipitate with other ORC
subunits but still eluted as a larger complex, we were inter-
ested to see whether this protein interacted with other cellular
proteins to understand how the protein is regulated or even
linked to the replication apparatus. [35S]Methionine-labeled
HeLa cell extracts prepared from asynchronous cells and cells
blocked at the different stages of the cell cycle were immuno-
precipitated using either anti-ORC6 antibody or preimmune
serum. Besides the 30-kDa ORC6, polypeptides of 35, 40, 65,
68, 72, 80, and 115 kDa were present specifically in the im-
mune lane (Fig. 5A). None of these proteins were recognized by
the anti-ORC6 antibodies in immunoblots, suggesting that
these cellular proteins are not precipitated because of cross-
reaction to anti-ORC6 antibody but are associated with hs-
ORC6. To examine whether there was any change in ORC6
associated proteins in G1 versus M, mevastatin blocked cells
(G1) were compared with nocodazole blocked cells (M). The
same polypeptides were present in the immunoprecipitates in
G1 or M.
ScORC6 is highly phosphorylated in the G1 phase of the cell
cycle by cyclin-Cdks (3). Sequence analysis of ORC6 did not,
however, show any obvious Cdk phosphorylation sites. To find
out whether ORC6 is phosphorylated in a cell cycle-specific
manner, we performed immunoprecipitation experiments us-
ing 32PO4-labeled HeLa cell extracts prepared from cells
blocked at the different stages of the cell cycle. ORC6 was very
weakly phosphorylated, but its phosphorylation level did not
change with the cell cycle (Fig. 5B). There were several phos-
pho-proteins of 35, 45, 60, 65, 70, and 80 kDa co-immunopre-
cipitated with ORC6. One phosphoprotein of 65 kDa was par-
ticularly prominent in the G1 phase of the cell cycle compared
with M phase cells. A 65-kDa protein co-immunoprecipitated
with ORC6 from [35S]methionine-labeled cell extracts, and the
abundance of this protein was not changed to the same extent
between G1 and M phase of the cell cycle (Fig. 5A). If the
65-kDa protein identified by [35S]methionine and 32PO4 label-
ing is the same, then cell cycle-regulated phosphorylation of an
ORC6-associated protein could be important for the regulation
of ORC6.
Localization of ORC6 in Human Cells—Because one compo-
nent of the replication initiation complex, CDC6, changes in-
tracellular localization through the phases of the cell cycle (28),
we examined by immunofluroscence whether ORC6 was simi-
larly regulated. Asynchronous culture of human U2OS osteo-
sarcoma cells was immunostained using preimmune or anti-
ORC6 antibody (Fig. 6). ORC6 is localized predominantly in the
nucleus consistent with the nuclear localization of other ORC
subunits.2 The fact that ORC6 was constitutively nuclear in all
cells in the asynchronous culture suggests that its intracellular
localization was not regulated through the phases of the cell
cycle.
DISCUSSION
We report here the identification of a sixth member of the
human origin recognition complex, ORC6. This protein is
highly homologous to dmORC6. dmORC6 is part of the six-
protein dmORC that is required for DNA replication in the
Drosophila and Xenopus egg extract. Strong homology with
Drosophila ORC6 and an equivalent mass of ;30 kDa suggests
that this is indeed the hsORC6 subunit. We also found that
2 K. C. Thome and A. Dutta, unpublished results.
FIG. 2. Characterization of anti-ORC6 antibody and abun-
dance of ORC6 through the cell cycle. A, bacterially produced
His6-tagged ORC6 (lanes 1 and 3) and 293T cell extracts (lanes 2 and 4)
were immunoblotted with anti-ORC6 antibody (lanes 1 and 2) or with
preimmune serum from the same rabbit (lanes 3 and 4). The positions
of ORC6 and His6-tagged ORC6 are indicated in the figure. B, HeLa
cells were synchronized in mitosis using nocodazole (40 mg/ml) for 24 h
and then released in drug free media. Whole cell extracts were prepared
at indicated hours after release from mitotic block and immunoblotted
using anti-ORC6 or anti-cyclin A or anti-ORC2 antibodies.
FIG. 3. Association of ORC6 with other ORC subunits. 293T cell
lysate was immunoprecipitated (IP) either by using anti-ORC2 or anti-
ORC6 antibodies (I) or their respective preimmune sera (PI) followed by
immunoblotting using anti-ORC1, 2, 3, 4, 5, and 6 antibodies. 5% of
lysate used for IP was loaded in the input lanes (Inp.).
FIG. 4. Gel filtration of ORC6 subunit from 293T cell extract.
293T cell extract was fractionated over a fast protein liquid chromatog-
raphy Superose 12 gel filtration column and alternate fractions (frac-
tions 11–29) were immunoblotted using anti-ORC2 or anti-ORC6 anti-
bodies. The positions of the molecular mass markers thyroglobulin (670
kDa), bovine gamma globulin (158 kDa), chicken ovalbumin (44 kDa),
and equine myoglobin (17 kDa) are shown on top. Input lanes were
loaded with 5% of the total lysate passed through the column.
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ORC6p does not co-immunoprecipitate with other ORC sub-
units under our experimental conditions. Although ORC sub-
units in yeast and early developmental stages of metazoa as-
sociate with each other in a stable holocomplex, the same is not
true for mammalian ORCs from somatic cells. Endogenous
hsORC2, 3, 4, and 5 subunits have been shown to interact with
each other by co-immunoprecipitation experiments using hu-
man cell extract (11, 22). Interestingly, hsORC1 has not been
shown to interact with other ORC subunits under normal con-
ditions. This suggests that stable complex of six ORC may not
be abundant in human somatic cells.
ORC6p expression level and subcellular localization is not
changed through the cell cycle. This finding is consistent with
the constitutive expression pattern of all other ORC protein
subunits through the cell cycle in human somatic cells (22, 23,
28, 30). In yeast too ORC is constitutively expressed through-
out the cell cycle. The G1-specific formation of the prereplica-
tion complex in yeast is attributed to the appearance of CDC6,
which is conceptually similar to the nuclear localization of
human CDC6 in G1.
Hs ORC6 interacts with many unidentified cellular proteins.
Identification of these proteins may help us to understand the
function of ORC6 in human DNA replication and other cellular
processes. Based on the hypothesis that human ORC will be
fundamentally similar to the yeast, Drosophila, and Xenopus
counterparts, it is likely that a complex of six subunits is
created in mammalian cells at origins of replication in G1. The
failure to isolate the complex may be due to the difficulties in
extraction of some of the ORC subunits (23, 30). ORC6-inter-
acting proteins may then be crucial for bridging ORC6 with
other ORC subunits on the chromatin in G1. One of the ORC6-
interacting phosphoproteins is hyperphosphorylated during G1
phase of the cell cycle and this may be important for ORC6
regulation.
The weak phosphorylation of human ORC6 contrasts with
that of yeast ORC6. In addition, the latter is unphosphorylated
in G1 and gets phosphorylated by Cdks at the onset of S phase
(3), whereas human ORC6 is constitutively phosphorylated
through the G1/S transition. Of the other ORC subunits, hu-
man ORC2 is constitutively phosphorylated through the cell
cycle,2 whereas human ORC1 is phosphorylated in M phase
(30).
In summary, we have identified a putative hsORC6 molecule
that is homologous to Drosophila ORC6. Although it does not
interact with the other ORC subunits in vivo, it will lead us one
step ahead to our ultimate goal of reconstituting the entire
human ORC in vitro. The results so far indicate significant
differences in the architecture and stability of human and yeast
ORC and might predict differences in how replication is regu-
lated in the two species.
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